Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Aug 31, 2024 | (FY)Aug 31, 2023 | (FY)Aug 31, 2022 | (FY)Aug 31, 2021 | (FY)Aug 31, 2020 | (FY)Aug 31, 2019 | (FY)Aug 31, 2018 | (FY)Aug 31, 2017 | (FY)Aug 31, 2016 | (FY)Aug 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 61.43%12.31B | 34.23%7.62B | -28.73%5.68B | -12.74%7.97B | -1.35%9.13B | 35.50%9.26B | -11.97%6.83B | 86.67%7.76B | -25.90%4.16B | 17.35%5.61B |
Net profit before non-cash adjustment | 149.72%7.2B | 37.01%2.88B | -51.85%2.11B | 18.77%4.37B | -40.99%3.68B | 27.07%6.24B | 9.94%4.91B | 34.04%4.47B | 1.00%3.33B | 43.82%3.3B |
Total adjustment of non-cash items | -27.80%3.6B | 50.24%4.99B | 4.05%3.32B | -8.94%3.19B | -3.02%3.5B | 11.83%3.61B | 5.25%3.23B | 15.34%3.07B | 21.91%2.66B | -6.61%2.18B |
-Depreciation and amortization | 0.27%2.93B | -1.08%2.92B | 9.46%2.95B | -4.87%2.7B | 12.02%2.83B | 6.75%2.53B | 6.86%2.37B | 2.64%2.22B | 17.14%2.16B | 22.82%1.84B |
-Reversal of impairment losses recognized in profit and loss | 26.81%648M | 43.94%511M | -8.97%355M | -27.91%390M | -8.61%541M | 33.03%592M | 11.81%445M | 1,106.06%398M | 94.12%33M | -66.40%17M |
-Share of associates | -98.38%18M | 1,467.61%1.11B | --71M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | -178.63%-206M | 11.97%262M | 65.96%234M | -34.72%141M | 54.29%216M | -37.78%140M | -16.97%225M | 18.34%271M | 46.79%229M | -76.16%156M |
-Net exchange gains and losses | 63.51%-27M | 86.55%-74M | -153.46%-550M | -720.00%-217M | -61.96%35M | 360.00%92M | 151.28%20M | -218.18%-39M | 353.85%33M | -129.55%-13M |
-Other non-cash items | -5.88%240M | -1.16%255M | 43.33%258M | 246.34%180M | -147.67%-123M | 51.76%258M | -23.08%170M | 7.80%221M | 15.17%205M | 106.90%178M |
Changes in working capital | 700.40%1.5B | -199.60%-250M | -38.33%251M | -79.06%407M | 426.72%1.94B | 54.55%-595M | -681.78%-1.31B | 112.26%225M | -1,544.88%-1.84B | -15.80%127M |
-Change in receivables | -165.55%-1.43B | 9.14%-537M | -180.41%-591M | 996.34%735M | 91.63%-82M | -782.88%-980M | 62.75%-111M | 19.46%-298M | -236.36%-370M | -141.06%-110M |
-Change in inventory | -125.55%-325M | 285.96%1.27B | -163.08%-684M | -130.81%-260M | 388.05%844M | 39.96%-293M | -388.00%-488M | 82.49%-100M | 19.01%-571M | -218.24%-705M |
-Change in payables | 408.71%1.63B | -388.52%-528M | 471.88%183M | -97.47%32M | 97.97%1.27B | 225.79%639M | -243.10%-508M | 143.99%355M | -178.89%-807M | 225.91%1.02B |
-Change in accrued expense | 105.35%384M | 37.50%187M | 1,336.36%136M | -107.48%-11M | -56.38%147M | 632.61%337M | -60.68%46M | -12.03%117M | 18.75%133M | 65.21%112M |
-Provision for loans, leases and other losses | 164.21%531M | -187.98%-827M | --940M | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
-Changes in other current assets | -89.69%-184M | -310.87%-97M | 24.32%46M | 236.36%37M | 103.12%11M | -287.91%-353M | -727.27%-91M | 95.55%-11M | -147.00%-247M | -23.03%-100M |
-Changes in other current liabilities | 218.21%891M | 26.70%280M | 275.40%221M | 47.72%-126M | -538.18%-241M | 135.03%55M | -196.91%-157M | 500.00%162M | 129.03%27M | -182.47%-93M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 4.32%-133M | 4.79%-139M | 17.05%-146M | -22.22%-176M | 14.29%-144M | -12.75%-168M | -6.43%-149M | -64.71%-140M | -51.79%-85M | -47.77%-56M |
Interest received (cash flow from operating activities) | -22.22%7M | 0.00%9M | 12.50%9M | -68.00%8M | 400.00%25M | -37.50%5M | 166.67%8M | 0.00%3M | 50.00%3M | -60.61%2M |
Tax refund paid | 17.05%-1.19B | -25.07%-1.44B | 59.15%-1.15B | -57.68%-2.81B | 19.49%-1.78B | -14.82%-2.22B | -54.03%-1.93B | 21.29%-1.25B | -32.01%-1.59B | 42.03%-1.21B |
Other operating cash inflow (outflow) | 150.00%1M | 0.00%-2M | -102.82%-2M | -86.37%71M | 521M | 0 | 41.94%-18M | 8.82%-31M | 15.00%-34M | -128.80%-40M |
Operating cash flow | 81.52%10.99B | 37.87%6.05B | -13.19%4.39B | -34.73%5.06B | 12.68%7.75B | 45.02%6.88B | -25.19%4.74B | 158.84%6.34B | -43.18%2.45B | 53.60%4.31B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 35.32%-1.89B | -9.58%-2.92B | -67.57%-2.66B | 29.95%-1.59B | -17.40%-2.27B | 8.14%-1.93B | -26.09%-2.1B | -23.30%-1.67B | 36.97%-1.35B | 17.67%-2.15B |
Net intangibles purchase and sale | -9.00%-739M | -23.50%-678M | -60.06%-549M | -7.52%-343M | 9.38%-319M | -155.07%-352M | 35.51%-138M | 57.87%-214M | -161.86%-508M | -301.35%-194M |
Net business purchase and sale | ---- | ---- | ---- | 140.66%159M | ---391M | ---- | ---- | ---- | -5.03%-209M | 61.81%-199M |
Net investment product transactions | 1,001.79%505M | 30.00%-56M | 93.31%-80M | -127.38%-1.2B | -431.31%-526M | ---99M | ---- | ---- | ---48M | ---- |
Advance cash and loans provided to other parties | 86.47%-77M | -67.85%-569M | -166.93%-339M | 19.62%-127M | 13.66%-158M | 71.27%-183M | -250.00%-637M | -87.63%-182M | ---97M | ---- |
Repayment of advance payments to other parties and cash income from loans | 14.86%85M | 25.42%74M | 25.53%59M | 9.30%47M | 34.38%43M | 33.33%32M | 50.00%24M | 60.00%16M | 0.00%10M | -59.03%10M |
Net changes in other investments | -192.23%-273M | 204.59%296M | -122.83%-283M | 51.15%-127M | 14.19%-260M | -43.60%-303M | 41.23%-211M | 15.53%-359M | -32.81%-425M | 65.80%-320M |
Investing cash flow | 38.04%-2.39B | 0.10%-3.85B | -21.35%-3.85B | 18.13%-3.18B | -36.74%-3.88B | 7.44%-2.84B | -27.35%-3.06B | 8.48%-2.41B | 7.69%-2.63B | 33.07%-2.85B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 97.94%-208M | -1,362.52%-10.11B | 27.87%-691M | -104.79%-958M | 3,445.57%20B | 153.21%564M | -2,617.95%-1.06B | -104.05%-39M | 327.56%962M | 158.12%225M |
Net common stock issuance | --0 | --0 | --0 | --0 | ---5.01B | ---- | ---- | ---- | ---- | ---- |
Increase or decrease of lease financing | 19.85%-323M | 17.25%-403M | 34.98%-487M | 0.40%-749M | -5.17%-752M | -7.04%-715M | 2.20%-668M | -18.37%-683M | -28.79%-577M | -51.52%-448M |
Cash dividends paid | -248.18%-1.06B | 64.89%-303M | 25.99%-863M | 2.59%-1.17B | -4.09%-1.2B | -33.41%-1.15B | -43.91%-862M | -56.40%-599M | -60.25%-383M | 75.02%-239M |
Net other fund-raising expenses | -8.55%-749M | 5.22%-690M | 17.74%-728M | -46.28%-885M | -43.03%-605M | -4.19%-423M | -78.85%-406M | -92.37%-227M | -168.18%-118M | -41.90%-44M |
Financing cash flow | 79.70%-2.34B | -315.38%-11.5B | 26.32%-2.77B | -130.21%-3.76B | 821.46%12.44B | 42.46%-1.72B | -93.54%-3B | -1,234.48%-1.55B | 77.08%-116M | 69.71%-506M |
Net cash flow | ||||||||||
Beginning cash position | -43.06%12.2B | -7.65%21.43B | -5.92%23.21B | 190.92%24.67B | 53.30%8.48B | -19.37%5.53B | 57.74%6.86B | -11.05%4.35B | 50.66%4.89B | -48.99%3.25B |
Current changes in cash | 167.43%6.27B | -316.72%-9.3B | -18.99%-2.23B | -111.50%-1.88B | 603.88%16.31B | 275.80%2.32B | -155.26%-1.32B | 905.74%2.39B | -130.96%-296M | 130.64%956M |
Effect of exchange rate changes | 56.52%108M | -84.87%69M | 10.41%456M | 444.17%413M | -15.38%-120M | -940.00%-104M | -107.94%-10M | 151.85%126M | -1,000.00%-243M | 672.97%27M |
Cash adjustments other than cash changes | --94M | ---- | -200.00%-1M | 200.00%1M | -100.14%-1M | 73,600.00%735M | ---1M | ---- | -100.15%-1M | --661M |
End cash Position | 53.03%18.67B | -43.06%12.2B | -7.65%21.43B | -5.92%23.21B | 190.92%24.67B | 53.30%8.48B | -19.37%5.53B | 57.74%6.86B | -11.05%4.35B | 50.65%4.89B |
Free cash flow | 240.00%8.36B | 108.30%2.46B | -62.23%1.18B | -39.43%3.13B | 12.58%5.16B | 83.29%4.59B | -43.88%2.5B | 656.88%4.46B | -70.12%589M | 1,194.42%1.97B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |